TENX
TENX
NASDAQ · Biotechnology

Tenax Therapeutics Inc

$1.87
+0.04 (+2.19%)
As of Aug 14, 3:16 PM ET ·
Analyst Consensus
Strong Buy
16
Analysts
High
Coverage
Buy 15 94%
Hold 1 6%
Sell 0 0%
Price Target
Analyst Price Target +1,682.4% upside
Low Target $30.09
Average Target $33.33
High Target $42.13
Current Price $1.87
Current
$1.87
Target
$33.33
$30.09 $33.33 avg $42.13
Scenario Analysis
Bear Case
$30.09
1,509.1%
Low target
Base Case
$33.33
+1,682.4%
Avg target
Bull Case
$42.13
+2,152.9%
High target
Risk/Reward
1.4x
Balanced
Price in Context
52-Week High
$19.40
-90.4% from high
52-Week Low
$5.78
+-67.6% from low
Target vs 52W High
$33.33
+71.8% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 38 82% $257.58 +3.3%
AMGN
Amgen Inc
Hold 43 49% $190.87 -54.0%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +162.1%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 37 81% $438.34 -13.3%
REGN
Regeneron Pharmaceuticals
Buy 37 70% $76.80 -90.4%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -53.9%
RVMD
Revolution Medicines Inc
Strong Buy 28 93% $114.11 -44.0%
BIIB
Biogen Inc
Buy 43 67% $91.45 -56.4%